NCT02667938View on ClinicalTrials.gov

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules

PHASE3CompletedINTERVENTIONAL
Enrollment

510

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

May 31, 2016

Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG

HCP1303 capsule 5/0.2mg

DRUG

HCP1303 capsule 5/0.4mg

DRUG

HGP1201

DRUG

HCP1303 capsule 5/0.2mg placebo

DRUG

HCP1303 capsule 5/0.4mg placebo

DRUG

HGP1201 placebo

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT02667938 - A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules | Biotech Hunter | Biotech Hunter